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ullous pemphigoid antigen 1 (BPAG1) is a member of
the plakin family with cytoskeletal linker properties.
Mutations in BPAG1 cause sensory neuron degenera-
tion and skin fragility in mice. We have analyzed the
BPAG1 locus in detail and found that it encodes different
interaction domains that are combined in tissue-speciﬁc
manners. These domains include an actin-binding domain
(ABD), a plakin domain, a coiled coil (CC) rod domain,
two different potential intermediate ﬁlament–binding do-
mains (IFBDs), a spectrin repeat (SR)-containing rod do-
main, and a microtubule-binding domain (MTBD). There
are at least three major forms of BPAG1: BPAG1-e (302
kD), BPAG1-a (615 kD), and BPAG1-b (834 kD). BPAG1-e
B
 
has been described previously and consists of the plakin
domain, the CC rod domain, and the ﬁrst IFBD. It is the pri-
mary epidermal BPAG1 isoform, and its absence that is the
likely cause of skin fragility in mutant mice. BPAG1-a is the
major isoform in the nervous system and a homologue of
the microtubule actin cross-linking factor, MACF. BPAG1-a
is composed of the ABD, the plakin domain, the SR-con-
taining rod domain, and the MTBD. The absence of
BPAG1-a is the likely cause of sensory neurodegeneration
in mutant mice. BPAG1-b is highly expressed in muscles,
and has extra exons encoding a second IFBD between the
plakin and SR-containing rod domains of BPAG1-a.
 
Introduction
 
Bullous pemphigoid antigen 1 (BPAG1)* is a member of
the plakin family with cytoskeletal linker properties (Ruhr-
berg and Watt, 1997). The epidermal isoform of BPAG1
(BPAG1-e) is made up of a coiled coil (CC) rod domain
 
flanked by globular NH
 
2
 
-terminal head and COOH-termi-
nal tail domains. The NH
 
2
 
-terminal head domain is homol-
ogous to that of other plakin family members and is called
the plakin domain. The COOH terminus consists of two
homologous repeats and has been proposed to be an inter-
mediate filament (IF)-binding domain (IFBD). BPAG1-e
links hemidesmosomes to keratin filaments. Interestingly,
mutations of the BPAG1 gene result in sensory neuron de-
generation in the mutant mouse, 
 
dystonia musculorum
 
 (
 
dt
 
)
(Brown et al., 1995). Three neuronal isoforms of BPAG1
(BPAG1-n or dystonin) with different NH
 
2
 
-terminal se-
quences have been reported (Brown et al., 1995; Guo et al.,
1995; Yang et al., 1999). These neuronal isoforms consist of
an actin-binding domain (ABD) that is made up of one or
two calponin homology subdomains, a plakin domain, a CC
rod domain, and an IFBD. The IFBD can interact with neu-
ronal IFs (Yang et al., 1996; Leung et al., 1999a).
 
Microtubule (MT) actin cross-linking factor (MACF) is a
divergent member of the plakin family (Leung et al., 1999b).
 
At its NH
 
2
 
 terminus, MACF exhibits high homology to the
NH
 
2
 
 terminus of BPAG1-n, including the ABD and the
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plakin domain. However, MACF does not contain a CC rod
domain or an IFBD. Instead, MACF bears a 23 spectrin re-
peat (SR)-containing rod domain and a novel COOH-termi-
nal MT-binding domain (MTBD). Recently, we character-
ized the COOH-terminal portion of a protein (MACF2) that
is highly homologous to the MTBD of MACF (Sun et al.,
2001). In this report, we describe a detailed characterization
of the BPAG1 locus and the alternatively spliced isoforms of
BPAG1 in mice. We found that MACF2 is structurally simi-
lar to MACF, and that it is an alternatively spliced form of the
BPAG1 gene; hence, we renamed it BPAG1-a. BPAG1-a ap-
pears to be the predominant form of BPAG1 expressed in the
nervous system. In striated muscle we discovered another
BPAG1 isoform that possesses a putative novel IFBD in the
center of the molecule, and we named this isoform BPAG1-b.
 
Results and discussion
 
Molecular cloning of BPAG1 isoforms
 
We cloned cDNAs of MACF2 by nested PCR. By sequen-
tially performing PCR on a mouse brain cDNA library with
primers specific for four EST clones (GenBank/EMBL/
DDBJ accession no. AI526522, AA668029, AA765549,
and AI058268) and for the end sequences of the previously
amplified PCR products, we obtained three consecutively
overlapping cDNAs that spanned 
 
 
 
9.7 kb of the 3
 
 
 
 coding
region of mouse MACF2. The 5
 
 
 
 portion of this compo-
site MACF2 cDNA displayed significant sequence homol-
ogy to a human genomic bacterial artificial chromosome
clone, RP1-61B2 (GenBank/EMBL/DDBJ accession no.
AL096710). This bacterial artificial chromosome clone was
arbitrarily divided into three segments: the first segment in-
Figure 1. The genomic structure of BPAG1 and the predicted architecture of BPAG1 isoforms. (A) The structure of the 5  portion of BPAG1 
gene is illustrated. The putative promoters are indicated by arrows. The plakin domain is encoded by 21 exons (black), whereas the CC rod 
domain and the IFBD1 are each coded by a single exon (light gray). The dark gray boxes represent exons specific for BPAG1-b that contain 
the IFBD2. Exons and cDNA (hatched boxes) that harbor a stop codon are marked. (B) Schematic representation of the domain structure of 
BPAG1 isoforms. The names of BPAG1 isoforms, their predicted molecular masses, and the length of their composite cDNAs are indicated. 
Bold lines underneath the schematic protein drawings represent nested PCR products. The names of individual domains are indicated, except 
for the EF-hand calcium binding motifs (small gray boxes) and the MT-binding Gas-2–related domain (hatched boxes). The numbers of the 
amino acids that mark the boundaries of each domain are also shown. 
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cluded most of the exons of the BPAG1 gene; the second
segment contained a putative exon with an 
 
 
 
5-kb ORF;
and the third segment was made up of many small exons
that encoded the SRs of MACF2 (Fig. 1 A).
By library screening and genomic PCR, we obtained
mouse genomic clones that were equivalent to this human
locus. An 
 
 
 
5-kb ORF-containing exon was located 
 
 
 
4 kb
downstream of the “last” exon of mouse BPAG1, and 
 
 
 
3 kb
upstream of a predicted exon of MACF2. Although the last
exon of BPAG1 contained an in frame stop codon and a
polyadenylation signal, the proximity of the predicted 
 
 
 
5-
kb ORF-containing exon and the lack of an in frame transla-
tion start codon common to humans and mice indicated
that MACF2 was an alternatively spliced product of the
BPAG1 gene. To dissect the potential alternatively spliced
transcripts we performed Northern blots with probes against
different domains of BPAG1 and MACF2 (described in a
later section). We found that MACF2 was an alternatively
spliced isoform of BPAG1, hence, we renamed it BPAG1-a.
Using these Northern blot results we performed PCR on
cDNAs prepared from appropriate tissues and identified
three major transcripts of BPAG1: BPAG1-e, BPAG1-a, and
BPAG1-b (Fig. 1 B).
 
Sequence analysis of BPAG1 isoforms
 
The composite BPAG1-a cDNA is 
 
 
 
17.2 kb (GenBank/
EMBL/DDBJ accession no. AF396878) and encodes a 615-
kD protein (Fig. S1 A). The domain structure of BPAG1-a
is similar to that of MACF (Fig. 1 B). The ABD and plakin
domains of BPAG1-a are identical to those reported for
BPAG1-n (Yang et al., 1996). However, the rod domain of
BPAG1-a is made up of 23 SRs (Fig. 1 B). BPAG1-a con-
tains two EF-hand motifs and an MTBD at its COOH ter-
minus (Sun et al., 2001). The primary sequences of MACF
and BPAG1-a share a 52% identity and a 70% homology,
suggesting that they originated from the same ancestral gene.
Most of the homologies are located at the NH
 
2 
 
and COOH
termini, whereas the sequences of the SRs are more diver-
gent.
The composite BPAG1-b cDNA is 
 
 
 
23.2 kb (GenBank/
EMBL/DDBJ accession no. AF396879) and codes for an
834-kD protein (Fig. S1 B). The transcript of BPAG1-b is
identical to that of BPAG1-a except that it has four addi-
tional exons in the middle of the molecule, including the
 
 
 
5-kb ORF-containing exon that was found in our ge-
nomic clone (Fig. 1 A). Part of the deduced amino acid se-
quence of the 
 
 
 
5-kb ORF exhibits significant homology to
the IFBD of BPAG1-e (Fig. 2); hence, we designated this
domain as IFBD2 and the COOH-terminal domain of
BPAG1-e/n as IFBD1. In contrast to IFBD1 which contains
two repeats, IFBD2 harbors only one repeat. Aside from the
IFBD2, the extra sequences of BPAG1-b do not show signif-
icant homology to other proteins. The composite cDNA of
mouse BPAG1-e was 
 
 
 
9.0 kb (GenBank/EMBL/DDBJ ac-
cession no. AF396877) and encoded a 302-kD protein (Fig.
S1 C). The protein structure of mouse BPAG1-e is similar
to its human orthologue (Sawamura et al., 1991).
 
Expression patterns of BPAG1 isoforms
 
We prepared probes against different domains of BPAG1
isoforms for Northern blot analysis. Three different hybrid-
ization patterns were obtained: the pattern in the brain was
identical to the spinal cord, the pattern in the heart was
identical to the skeletal muscles, and the pattern in the skin
was unique. BPAG1-a mRNA was the only BPAG1 mRNA
detected in the brain and the spinal cord (Fig. 3 B and un-
published data). Probes specific for the CC rod domain and
IFBD1 failed to recognize any mRNAs in the brain and spi-
nal cord, indicating that BPAG1-n is not a major isoform
in the central nervous system. The previously reported
BPAG1-n mRNAs in the nervous system are likely due to
crosshybridization of BPAG1-a with the BPAG1-n probes,
as the probes used in these studies were against the ABD and
the plakin domain, common to BPAG1-a and BPAG1-n
(Bernier et al., 1995a, 1995b, 1998; Brown et al., 1995;
Yang et al., 1996; Dalpe et al., 1998). In the heart, BPAG1-b
was the predominant BPAG1 isoform. The mRNA of
BPAG1-b was labeled with the IFBD2 probe and was larger
than the mRNA of BPAG1-a (Fig. 3 B). These results are
consistent with previous studies that showed a larger BPAG1
message in skeletal muscles and the heart with probes spe-
cific for the 5
 
 
 
 portions of BPAG1-n (Bernier et al., 1995b;
Dalpe et al., 1999). Also in agreement with other studies
(Yang et al., 1996; Dalpe et al., 1998), the shorter BPAG1-e
transcripts were detected in the skin.
To detect less abundant mRNAs, we performed ribonu-
clease protection assays (RPAs) and reverse transcriptase
(RT)-PCR experiments (Fig. 3 C). Using a riboprobe spe-
cific for IFBD1 common to BPAG1-e and BPAG1-n (Fig. 1
B), we obtained signals only from the skin, indicating that
BPAG1-n could not be detected in the brain and the heart
by RPA. In contrast, the IFBD2 riboprobe detected high
levels of BPAG1-b mRNAs in the heart and low levels in the
brain. The SR rod domain riboprobe, which does not distin-
guish BPAG1-a from BPAG1-b, detected strong signals
from the brain and the heart, and a weak signal from the
skin. The major structural differences between BPAG1-a,
BPAG1-b, and BPAG1-e (or BPAG1-n) are in the regions
following the plakin domain: BPAG1-a contains the SR rod
domain, BPAG1-b contains IFBD2, and BPAG1-e (and
BPAG1-n) contains the CC rod domain (Fig. 1 B). We used
three sets of PCR primers to distinguish these isoforms. The
forward primers were designed against the plakin domain,
Figure 2.  Primary sequences of mouse BPAG1 isoforms and com-
parison of the IFBDs. The IFBD of BPAG1-b (IFBD2; amino acids 
1563–1931 of BPAG1-b) is compared with the IFBD of BPAG1-e 
(IFBD1; amino acids 2184–2598 of BPAG1-e). Identical amino 
acids are shaded in black with white letters, whereas the conserved 
amino acid changes are shaded in gray. 
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published data). These probes gave no signal in the nervous
system, confirming that the BPAG1-n isoforms were not ex-
pressed in detectable quantities. The IFBD2 probe specifi-
cally labeled BPAG1-b mRNA in myocardium, skeletal
muscle masses, vertebrae cartilage, and epithelia of the
tongue (Fig. 4 B). More ubiquitous labeling patterns were
observed with probes prepared for the ABD, plakin domain,
SR-containing rod domain, and MTBD that would label
BPAG1-a and BPAG1-b (Fig. 4 C and unpublished data).
Strong signals were found with these probes in nervous tis-
sues, especially at the pituitary primordium, the cranial gan-
glia, and the dorsal root ganglia (DRG). To determine the
major form of BPAG1 expressed in the DRG, we hybridized
a series of adjacent transverse sections with probes against
various domains. Hybridization signals were obtained only
with probes against the ABD, plakin domain, SR-containing
rod domain, and MTBD, but not with the CC rod domain,
IFBD1, and IFBD2 probes. These results demonstrated that
BPAG1-e, BPAG1-n, and BPAG1-b are not expressed in
high quantities in the DRG, and that the major form there
is BPAG1-a (Fig. 4, D–F, and unpublished data).
We also compared the tissue distributions of MACF and
BPAG1-a by in situ hybridization. Adjacent transverse sec-
and the reverse primers were specific for the SR rod domain,
IFBD2, and CC rod domain (Fig. 3 A). All PCR products,
including the 
 
 
 
-actin control, were 
 
 
 
500 bp in length. As
shown in Fig. 3 D, BPAG1-a was the most abundant iso-
form in the brain, although BPAG1-b was also present. In
contrast, the heart contained higher amounts of BPAG1-b
than BPAG1-a. In the heart and brain, no BPAG1-n (or
BPAG1-e) mRNA was detected under these PCR condi-
tions. High levels of BPAG1-e mRNA were found in the
skin, where BPAG1-a and BPAG1-b mRNAs were also
present in lower amounts. In an attempt to detect trace
amounts of BPAG1-n mRNA in the brain, we performed
35 cycles of PCR using the BPAG1-e/n primer set and ob-
tained a weak signal (unpublished data), implying that small
amounts of BPAG1-n (or BPAG1-e) are present in the
brain.
To extend our studies on the distribution of BPAG1 iso-
forms during development, we used probes corresponding
to various domains of BPAG1 for in situ hybridization anal-
ysis on mouse embryonic day E14.5 embryos. The hybrid-
ization patterns of probes against the CC rod domain and
IFBD1 were identical, as both labeled the epidermis and
mucosal epithelia along the digestive tract (Fig. 4 A and un-
Figure 3.  Analyses of BPAG1 mRNAs. (A) A schematic diagram showing the structure of the BPAG1 gene. Bold gray lines underneath indi-
vidual domains represent the probes used for Northern blot (NB) analysis and in situ hybridizations. The positions of riboprobes (bold lines in 
black) used for RPA and oligonucleotide primers (arrows) used for RT-PCR analyses are illustrated. The names of the riboprobes corresponded 
to the BPAG1 structural domains that the riboprobes recognized. The primer sets were named after the BPAG1 isoforms that they amplified. 
(B) Northern blot analysis of BPAG1 isoforms. The positions of the 17-kb brain MACF mRNA and the 2-kb RNA standard are marked. The 
 -actin probe also detected other actin isoforms. (C) RPA analysis of BPAG1 isoforms. BPAG1 isoforms that contained the IFBD1 domain 
were only detected in skin. BPAG1-b transcripts that could be protected by IFBD2 probe were found in large amounts in the heart and small 
amounts in the brain. The SR-containing rod domain probe that protected both BPAG1-a and BPAG1-b mRNAs gave strong signals in brain 
and heart and weak signals in skin. Marker standards (100, 200, and 300 bp) are indicated on the left of each panel. (D) RT-PCR analyses of 
BPAG1 isoforms. The highest amounts of BPAG1-a and BPAG1-b were observed in brain and heart, respectively. BPAG1-e mRNAs were 
only found in the skin, whereas no BPAG1-e/n mRNAs were detected in the brain or the heart with these RT-PCR settings. 
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tions of E14.5 embryos were hybridized with the MTBD
probes from MACF and BPAG1-a (note that this BPAG1-a
probe will not distinguish between BPAG1-a and BPAG1-
b). The expression of BPAG1-a in the spinal cord was in a
gradient with higher levels in the ventral horn, as compared
with the homogenous expression pattern of MACF (Fig. 5,
A and B). Of note is the observation that BPAG1-a was ex-
pressed in much higher quantities than MACF in the DRG.
In the vertebrae, BPAG1-a and/or BPAG1-b mRNAs were
detected in developing bone cartilage, whereas MACF ex-
pression appeared to be more confined in the surrounding
mesenchymal tissues (Fig. 5, C and D). Inside the thoracic
 
cage, higher expression levels of BPAG1-b were detected in
the heart, whereas MACF was more dominant in the lung.
 
Putative functions of BPAG1 isoforms
 
BPAG1-a is the primary isoform of BPAG1 expressed in the
nervous system, including the DRGs that are severely degen-
erated in 
 
dt
 
 mice. The 
 
dt
 
 DRG sensory neurons display ab-
normal accumulations of neuronal IFs and perturbed MTs
(Dalpe et al., 1998; Yang et al., 1999). The disruption of the
cytoskeleton network in these defective sensory neurons can-
not be rescued by the removal of neurofilaments, suggesting
that axonal swellings packed with neurofilaments are the re-
sult instead of of the cause of the sensory neuron degenera-
tion in 
 
dt
 
 mice (Yang et al., 1999). As BPAG1-a possesses
a well-defined MTBD and is the predominant form of
BPAG1 expressed in the nervous system, it is likely that the
disorganization of the MT network in
 
 dt
 
 neurons is due to
the absence of BPAG1-a.
Like MACF, BPAG1-a is a mammalian homologue of the
 
Drosophila
 
 protein kakapo/short stop. Mutations in the
short stop/kakapo gene result in defects in axonal out-
growth, as well as in the local development of dendritic pro-
cesses (Prokop et al., 1998; Lee et al., 2000). During early
development, the growth cones of both sensory and motor
neurons fail to continue advancing after formation of the
normal trajectory. By analogy, the neuropathology of 
 
dt
 
mice could be the result of defects in axonal outgrowth and/
or dendritic sprouting in sensory neurons. However, even
Figure 4.  In situ hybridization of E14.5 embryos. (A) Sagittal 
section of mouse embryo hybridized with probe specific for the 
IFBD1. Hybridization signal was detected in the skin (short arrow) 
and mucosal epithelia of the digestive tract (long arrow). The 
weaker signal inside the trunk was apparently background hybrid-
ization, since it did not display any structural pattern. An identical 
hybridization pattern was obtained with a probe against the CC rod 
domain. (B) Sagittal section of mouse embryo hybridized with probe 
specific for the IFBD2. Strong hybridization signal was detected in 
the tongue (long arrow), heart ( ), skeletal muscle masses at the 
back (short arrow), and bone cartilage of the vertebrae ( ). Back-
ground hybridization was also apparent in the trunk. (C) Sagittal 
section of mouse embryo hybridized with probe specific for the 
MTBD. Similar hybridization patterns were also found with probes 
against the SR-containing rod domain and the ABD. High expres-
sion levels of BPAG1 isoforms that contain these domains were 
observed in the tongue (long arrow), the thymus ( ), and bone carti-
lage of the vertebrae ( ). In the nervous system, particularly strong 
signal was detected at the pituitary primordium (short arrow). Adja-
cent transverse sections hybridized with probes against the CC rod 
domain (D), IFBD1 (E), and MT-binding domain (F). Probes against 
the CC rod domain and IFBD1 detected BPAG1-e mRNA in the skin 
only. BPAG1-a labeled by the MTBD probe is highly expressed in 
the DRG (arrow). Bars: (A–C) 2 mm; (D–F) 0.5 mm.
Figure 5.  Differential distribution of MACF and BPAG1-a/b. 
Adjacent transverse (A, B, and E–H) and sagittal (C and D) sections 
of embryonic-day-14.5 embryos were hybridized with probes 
prepared for the MTBD of BPAG1-a /b (A, C, E, and G) and MACF 
(B, D, F, and H). Hybridization signal of BPAG1-a was stronger than 
that of MACF in the DRG (short arrows, A and B) and metanephros 
(long arrows, A and B). Interestingly, there is a gradient of BPAG1-a/b 
distribution in the spinal cord with stronger signals detected on the 
ventral side (A). Note that BPAG1-a mRNA was expressed in the 
cartilage of the vertebrae, whereas MACF mRNA was expressed 
mostly in the mesenchymal tissues surrounding the developing 
vertebrae (C and D). Strong signals for BPAG1-b and MACF were 
found in the heart (E) and the lungs, respectively (H). Bars: (A and C) 
0.5 mm; (H) 0.1 mm.  
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though BPAG1-a is expressed broadly in the nervous system,
only sensory neurons of the DRG degenerated in the 
 
dt
 
mice. A possible explanation is that MACF can carry out the
same functions as BPAG1-a. As DRG neurons express less
MACF, there is less compensation from MACF for the loss
of BPAG1-a, thus resulting in degeneration.
BPAG1-b is structurally similar to BPAG1-a, except that
it has an additional putative IFBD in the middle of the mol-
ecule. Hence, BPAG1-b could potentially associate with mi-
crofilaments, IFs, and MTs; however, this remains to be
shown. BPAG1-b is more confined to muscles, and its ab-
sence may be responsible for the muscle weakness observed
in 
 
dt
 
 mice (Dalpe et al., 1999). The transcripts for the epi-
thelial-specific BPAG1-e can be detected in the epidermis
and mucosal epithelia of the digestive tracts (Fig. 4 A).
BPAG1-e anchors keratin filaments to hemidesmosomes
and the skin of BPAG1-null mice is more fragile in its ab-
sence (Guo et al., 1995).
We did not detect mRNAs of the proposed BPAG1-n iso-
forms in the central nervous system by Northern blot analy-
ses, RPA, and in situ hybridization. However, when we per-
formed 35 cycles of RT-PCR, we detected trace amounts of
BPAG1 transcripts that have the plakin domain connected
to the CC rod domain, presumably the BPAG1-n isoforms.
Previously, independent studies have reported that BPAG1-n
is widely expressed in the nervous system. However, the
probes and antibodies used in these studies recognize not
only BPAG1-n, but also BPAG1-a and BPAG1-b (Bernier
et al., 1995b; Dowling et al., 1997; Dalpe et al., 1998; Yang
et al., 1999). In conclusion, we propose that BPAG1-a is the
primary form of BPAG1 expressed in the nervous system,
and that its deficiency could account for the neurological
phenotype observed in 
 
dt
 
 mice.
 
Materials and methods
 
Molecular cloning
 
cDNAs of BPAG1-a and BPAG1-b were obtained from QUICK-Clone™
cDNA (CLONTECH Laboratories, Inc.) by PCR using Advantage 2 poly-
merase (CLONTECH Laboratories, Inc.) or Pfu polymerase (Stratagene). To
isolate cDNAs of BPAG1-e, RT-PCR was carried out on purified mouse
skin total RNA using OneStep RT-PCR kit (QIAGEN). All procedures were
conducted according to manufacturers’ protocols. Genomic PCR was per-
formed on purified mouse 129SvJ genomic DNA using Pfu polymerase
(Stratagene). All PCR products were cloned into pCR2.1-TOPO vector (In-
vitrogen) for sequencing. Mouse 129SvEvTacfBR lambda phage genomic
library (Stratagene) was screened with a human cDNA probe that encoded
the IFBD of BPAG1-b. After screening 5 
 
 
 
 10
 
7
 
 plaques, one positive clone
was recovered and characterized.
 
Northern blot analysis
 
The boundaries of the probes used were: ABD probe (nt 1–915 of BPAG1-
a); plakin probe (nt 2549–3184 of BPAG1-a); CC rod domain probe (nt
4870–5383 of BPAG1-e); IFBD1 probe (nt 6491–7601 of BPAG1-e); IFBD2
probe (nt 5937–6655 of BPAG1-b); SR-containing rod domain probe (nt
11987–12660 of BPAG1-a); and MTBD probe (nt 15241–16143 of
BPAG1-a). 30 
 
 
 
g of total RNA was resolved by electrophoresis in 0.8%
formaldehyde agarose gel. To enhance the transfer of large-size RNAs, gels
were treated with 0.05 M sodium hydroxide for 20 min before blotting
onto nylon membranes. Hybridization was carried out at 68
 
 
 
C in hybrid-
ization buffer (6
 
 
 
 SSC, 2
 
 
 
 Denhardt’s reagent, and 0.1% SDS) overnight.
The membranes were washed once with SSC and 0.1% SDS at room tem-
perature, and three times with 0.2
 
  
 
SSC and 0.1% SDS at 68
 
 
 
C.
 
RPA
 
Riboprobes were synthesized and labeled with biotinylated UTP using
 
MAXIscript in vitro transcription kit (Ambion). The IFBD1 antisense probe
included nt 7675–7852 of BPAG1-e, whereas the IFBD2 and SR-contain-
ing rod domain antisense probes encompassed nt 6352–6583 and nt
18401–18688 of BPAG1-b, respectively. The template for the actin ribo-
probe was supplied by the manufacturer. RPAs were performed according
to the manufacturer’s protocol (RPA III; Ambion).
 
RT-PCR analysis
 
RT-PCR was performed using Titanium OneStep RT-PCR kit (CLONTECH
Laboratories, Inc.). The forward primer recognized the plakin domain, 5
 
 
 
-
ATTCAAGAGTTCATGGACCTACGGACAC-3
 
 
 
. The isoform-specific re-
verse primers were: BPAG1-a, 5
 
 
 
-TAATTAGGCGGTTTTCAGTCTGGGT-
GAG-3
 
 
 
; BPAG1-b, 5
 
 
 
-CAATAAGGCCTCTTAAAACTGCCTGAAA-3
 
 
 
; and
BPAG1-e/n, 5
 
 
 
-TTTCCTGCAGCTGGCTCCGGAAGTTGCG-3
 
 
 
. The actin
primer set was provided by the manufacturer. 0.2 
 
 
 
g of the total RNAs
from various tissues was used for each reaction. The RT-PCR cycling pa-
rameters included an RT incubation step at 50
 
 
 
C for 60 min, followed by
an RT step at 94
 
 
 
C for 5 min, 25 cycles at 94
 
 
 
C for 30 s and at 68
 
 
 
C for 2
min, and a final extension step of 68
 
 
 
C for 5 min. 3 
 
 
 
l of the reaction prod-
ucts was subjected to electrophoresis. For the skin samples, 20 
 
 
 
l of the re-
action products was used. The PCR products were sequenced to confirm
their identities.
 
In situ hybridization
 
Both sagittal and transverse cryostat sections were prepared from E14.5
mouse embryos. Templates used for the generation of riboprobes were
constructs obtained by cloning the Northern blot probes described above
into pGEM7 vectors (Promega). Both sense and antisense [
 
35
 
S]UTP–labeled
cRNA transcripts were synthesized in vitro using Riboprobe Gemini Sys-
tems (Promega) and purified using Sephadex G-50 columns (Roche). In
situ hybridization was conducted as described previously (Zheng et al.,
1998). Hybridization with sense control probes yielded low background
staining in all cases.
 
Online supplemental material
 
The primary deduced amino acid sequences of the three major isoforms of
mouse BPAG1 described in this paper, BAG1-a, BAG1-b, and BAG1-e,
are available online as Fig. S1 at http://www.jcb.org/cgi/content/full/
200012098.
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